Chief Operating Officer of Leading India-based CRO, Max Neeman International Featured as One of India's 'Top 10 Women Achievers

RESEARCH TRIANGLE PARK, N.C., Dec. 1, 2010 /PRNewswire/ -- Max Neeman International announced today that Dr. Renu Razdan has been featured in the November issue of BioSpectrum India as a prominent female achiever in the Life Sciences community with valuable guidance as to what it takes to be a leader.  Her insightful Q&A interview stresses that "a good work environment is critical for success."

Working for India's fastest growing CRO has given Dr. Razdan valuable insight to provide the following tips for business women in this industry to succeed:  risk-taking ability, being passionate about work, willingness to work hard, capability to develop a great team and ability to turn challenges into opportunities.  These qualities align with Max Neeman's corporate culture allowing all employees equal opportunities to excel; where individual talents and skills are utilized, team work and delivering excellence is promoted and valued.

Dr. Ajoy Kumar, CEO of Max Neeman International states, "We are very proud of Dr. Razdan and grateful for her valuable contributions over the years.  She has grown with the company and is a credit to the organization, especially in regards to teamwork and client satisfaction."

Dr. Razdan has proven that for a woman, the best way to overcome stereotypical views is to stay committed and focused on your objectives while persistently striving to achieve the highest quality standards and client satisfaction.  "Max Neeman has provided a nurturing environment, allowing me to succeed and indeed thrive while promoting India and our CRO as the most strategic venues for your clinical research needs."

About Max Neeman International

Max Neeman International is a leading India-based CRO. Our specialty is that we offer services for the successful conduct of Phase I-IV clinical trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in over 31 cities with 6 regional offices.  Contact Donald Swankie, Vice President of Business Development via email to [email protected] or call +1.919.424.3345.  For more information please visit www.neeman-medical.com.

SOURCE Max Neeman International

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.